OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.63
-0.01 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
2.70
2.50%
After-hours: Aug 15, 2025, 06:35 PM EDT
OKYO Pharma Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 561.70 | 561.70 | n/a | 2.07K | 1.93K | 1.97K | 1.66K | 1.21K | 940.88 | 890.19 | 16.54K | 812.51 | 10.12K | 1.02K | 3.19K | 201.30 |
Gross Profit | -561.7 | -561.7 | n/a | -2.07K | -1.97K | -1.97K | -1.66K | -1.21K | -940 | -890.19 | -16.54K | -812.51 | -10.12K | -1.02K | -3.19K | -201.3 |
Operating Income | -1.67K | -1.67K | n/a | -4.37K | -3.78K | -3.85K | -5.54M | -2.28K | -3.44M | -1.31K | -2.78M | -985.4 | -2.67M | -1.07K | -1.11M | -215.92 |
Interest Income | n/a | n/a | n/a | n/a | n/a | 39.99 | n/a | n/a | n/a | 0.37 | n/a | 0.37 | n/a | 0.23 | 0.20 | 0.20 |
Pretax Income | -2.05K | -2.05K | n/a | -4.37K | -3.82K | -3.9K | -5.53M | -2.28K | -3.47M | -1.31K | -2.74M | -985.76 | -2.83M | -1.43K | -1.17M | -301.07 |
Net Income | -1.34K | -1.34K | n/a | -4.41K | -3.82K | -3.89K | -5.53M | -2.28K | -2.88M | -1.09K | -2.55M | -917.73 | -2.8M | -1.04K | -1.17M | -243.01 |
Selling & General & Admin | 791.71K | n/a | n/a | n/a | n/a | n/a | 2.94M | n/a | 2.63M | n/a | 2.28M | n/a | 2.52M | n/a | 1.07M | n/a |
Research & Development | 1.11K | 1.11K | n/a | 2.3K | 1.84K | 1.88K | 2.6M | 1.07K | 815.94K | 422.00 | 479.93K | 172.89 | 139.72K | 51.80 | 37.04K | 18.12 |
Other Expenses | n/a | n/a | n/a | 0.00 | n/a | -0.00 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.11K | 1.11K | n/a | 2.3K | 1.84K | 1.88K | 5.54M | 1.07K | 3.44M | 422.00 | 2.76M | 172.89 | 2.66M | 70.84 | 1.11M | 18.12 |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.67K | 1.67K | n/a | 4.37K | 3.78K | 3.85K | 5.54M | 2.28K | 3.44M | 1.31K | 2.78M | 985.40 | 2.67M | 1.05K | 1.11M | 242.78 |
Income Tax Expense | 708.92 | 708.92 | n/a | 41.41 | 6.10 | 6.10 | -2.94 | n/a | -591K | 222.69 | -189K | 68.03 | -25.85K | 9.59 | 86.11 | 0.03 |
Shares Outstanding (Basic) | 33.57M | 33.57M | 25.71M | 25.71M | 22.87M | 22.87M | 21.64M | 21.64M | 16.12M | 16.12M | 14.01M | 14.01M | 10.55M | 10.55M | 10.15M | 10.15M |
Shares Outstanding (Diluted) | 33.57M | 33.57M | 25.71M | 25.71M | 22.87M | 22.87M | 21.64M | 21.64M | 16.12M | 16.12M | 14.01M | 14.01M | 10.55M | 10.55M | 10.14M | 10.14M |
EPS (Basic) | -0.00 | -0.00 | n/a | -0.00 | -0.00 | -0.00 | -0.26 | -0.00 | -0.18 | -0.00 | -0.18 | -0.00 | -0.27 | -0.00 | -0.11 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | n/a | -0.00 | -0.00 | -0.00 | -0.26 | -0.00 | -0.18 | -0.00 | -0.18 | -0.00 | -0.27 | -0.00 | -0.11 | -0.00 |
EBITDA | -1.67K | -1.67K | n/a | -4.37K | -3.85K | -3.85K | -5.54M | -2.77K | -3.44M | -1.77K | -2.76M | -1.36K | -2.66M | -1.46K | -1.11M | -267.29 |
EBIT | -1.67K | -1.67K | n/a | -4.37K | -3.85K | -3.85K | -5.53M | -2.77K | -3.47M | -1.77K | -2.73M | -1.36K | -2.83M | -1.46K | -1.16M | -267.54 |
Depreciation & Amortization | 1.27K | 0.60 | n/a | 1.04 | 1.07 | 1.07 | 1.66K | 0.83 | n/a | 0.64 | 16.54K | 0.54 | 10.12K | 0.51 | 3.19K | 0.26 |